Jan Johannessen Biography and Net Worth

Director of Twist Bioscience


Jan Johannessen serves as Independent Director of the Company. Mr. Johannessen currently serves as an advisor to iGlobe Partners, a venture capital company. Mr. Johannessen served as Chief Operating Officer and Secretary at Conexant Systems, LLC, a semiconductor company, from May 2013 to August 2017 and also served as its Chief Financial Officer from May 2013 to May 2016 and as its Chief Executive Officer from May 2016 to August 2017. Mr. Johannessen served as Chief Financial Officer and Secretary at REC Silicon ASA, a company listed on the Oslo stock exchange from August 2008 to May 2013. He served as Interim Chief Executive Officer and President at Lattice Semiconductor Corporation, a publicly traded company, from May 2008 to August 2008 and as Chief Financial Officer and Secretary at Lattice Semiconductor Corporation from December 2003 to May 2008. Mr. Johannessen holds a B.S. in Business from the University of Houston, and a MBA in International Business from Arizona State University. Our board of directors believes that Mr. Johannessen brings extensive executive experience in the technology industry and financial and accounting expertise, which qualifies him to serve as one of our directors.

What is Jan Johannessen's net worth?

The estimated net worth of Jan Johannessen is at least $233,359.34 as of May 19th, 2021. Mr. Johannessen owns 6,898 shares of Twist Bioscience stock worth more than $233,359 as of March 18th. This net worth approximation does not reflect any other assets that Mr. Johannessen may own. Learn More about Jan Johannessen's net worth.

How do I contact Jan Johannessen?

The corporate mailing address for Mr. Johannessen and other Twist Bioscience executives is 681 GATEWAY BLVD., SOUTH SAN FRANCISCO CA, 94080. Twist Bioscience can also be reached via phone at (800) 719-0671 and via email at [email protected]. Learn More on Jan Johannessen's contact information.

Has Jan Johannessen been buying or selling shares of Twist Bioscience?

Jan Johannessen has not been actively trading shares of Twist Bioscience during the last ninety days. Most recently, Jan Johannessen sold 5,000 shares of the business's stock in a transaction on Wednesday, February 16th. The shares were sold at an average price of $59.20, for a transaction totalling $296,000.00. Learn More on Jan Johannessen's trading history.

Who are Twist Bioscience's active insiders?

Twist Bioscience's insider roster includes William Banyai (Insider), Robert Chess (Director), Keith Crandell (Director), Mark Daniels (Insider), Patrick Finn (Insider), Paula Green (SVP), Jan Johannessen (Director), Emily Leproust (CEO), James Thorburn (CFO), and Patrick Weiss (COO). Learn More on Twist Bioscience's active insiders.

Are insiders buying or selling shares of Twist Bioscience?

In the last year, Twist Bioscience insiders bought shares 1 times. They purchased a total of 10,000 shares worth more than $132,000.00. In the last year, insiders at the sold shares 6 times. They sold a total of 6,743 shares worth more than $242,057.80. The most recent insider tranaction occured on March, 14th when insider Dennis Cho sold 93 shares worth more than $3,217.80. Insiders at Twist Bioscience own 3.9% of the company. Learn More about insider trades at Twist Bioscience.

Information on this page was last updated on 3/14/2024.

Jan Johannessen Insider Trading History at Twist Bioscience

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/16/2022Sell5,000$59.20$296,000.00View SEC Filing Icon  
11/17/2021Sell5,000$115.17$575,850.00View SEC Filing Icon  
8/18/2021Sell5,000$97.11$485,550.00View SEC Filing Icon  
5/19/2021Sell5,000$88.39$441,950.006,898View SEC Filing Icon  
See Full Table

Jan Johannessen Buying and Selling Activity at Twist Bioscience

This chart shows Jan Johannessen's buying and selling at Twist Bioscience by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Twist Bioscience Company Overview

Twist Bioscience logo
Twist Bioscience Corporation engages in the manufacture and sale of synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels, primarily used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, the company provides synthetic SARS-CoV-2 RNA reference sequences as positive controls for the development of both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries used for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
Read More

Today's Range

Now: $33.83
Low: $32.87
High: $34.52

50 Day Range

MA: $36.65
Low: $32.28
High: $41.50

2 Week Range

Now: $33.83
Low: $11.46
High: $43.21

Volume

634,175 shs

Average Volume

995,473 shs

Market Capitalization

$1.96 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.64